Steven Bariahtaris
Finanzdirektor/CFO bei Liquidia Technologies, Inc.
Vermögen: - $ am 30.04.2024
Profil
Steven Bariahtaris is currently the Chief Financial Officer at Liquidia Technologies, Inc. He previously worked as an Independent Director at Carmell Corp.
and as the Chief Audit Executive & Worldwide Vice President at Johnson & Johnson Services, Inc. He also briefly served as the Chief Financial Officer at Liquidia Corp.
Mr. Bariahtaris received his undergraduate degree from Cornell University and his MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.07.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Steven Bariahtaris
| Unternehmen | Position | Beginn |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Finanzdirektor/CFO | 20.08.2020 |
Ehemalige bekannte Positionen von Steven Bariahtaris
| Unternehmen | Position | Ende |
|---|---|---|
| CARMELL CORPORATION | Direktor/Vorstandsmitglied | 31.08.2023 |
| LIQUIDIA CORPORATION | Finanzdirektor/CFO | 30.11.2020 |
Johnson & Johnson Services, Inc.
 Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Johnson & Johnson Services, Inc. provides home and health care services. The company is based in New Brunswick, NJ and was founded in 1886. | Finanzdirektor/CFO | - |
Ausbildung von Steven Bariahtaris
| Cornell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LIQUIDIA CORPORATION | Health Technology |
| CARMELL CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Johnson & Johnson Services, Inc. provides home and health care services. The company is based in New Brunswick, NJ and was founded in 1886. | Health Technology |
